References
- SEER Cancer Stat Facts: Leukemia. Bethesda (MD): National Cancer Institute; 2019.
- Meyers J, Yu Y, Kaye JA, et al. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013;11(3):275–286.
- Bryant AL, Deal AM, Walton A, et al. Use of ED and hospital services for patients with acute leukemia after induction therapy: one year follow-up. Leuk Res. 2015;39(4):406–410.
- LeBlanc TW, Egan PC, Olszewski AJ. Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia. Blood. 2018;132(7):717–726.
- Project HCaU. Clinical classifications software (CCS) for ICD-10-PCS; 2019. Available from: https://www.hcup-us.ahrq.gov/toolssoftware/ccs10/ccs10.jsp
- Cannas G, Pautas C, Raffoux E, et al. Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial. Leuk Lymphoma. 2012;53(6):1068–1076.
- Ali AM, Weisel D, Gao F, et al. Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen. Cancer Med. 2017;6(12):2814–2821.
- Howell DS, Roman E, Garry AC, et al. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med. 2011;25(6):630–641.
- Preston NJ, Hurlow A, Brine J, et al. Blood transfusions for anaemia in patients with advanced cancer. Cochrane Database Syst Rev. 2012;CD009007.
- Odejide OO, Cronin AM, Earle CC, et al. Why are patients with blood cancers more likely to die without hospice? Cancer. 2017;123(17):3377–3384.
- To THM, LeBlanc TW, Eastman P, et al. The prospective evaluation of the net effect of red blood cell transfusions in routine provision of palliative care. J Palliat Med. 2017;20(10):1152–1157.
- Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.
- Howell DA, Roman E, Cox H, et al. Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy. BMC Palliat Care. 2010;9:9.
- Ho TH, Barbera L, Saskin R, et al. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario. J Clin Oncol. 2011;29(12):1587–1591.
- Lowe JR, Yu Y, Wolf S, et al. A cohort study of patient-reported outcomes and healthcare utilization in acute myeloid leukemia patients receiving active cancer therapy in the last six months of life. J Palliat Med. 2018;21(5):592–597.